The landscape of cell and gene therapy manufacturing is experiencing a transformative evolution, fueled by advancements in technology and process optimization. This shift holds the promise of revolutionizing the production of therapies aimed at curing previously incurable diseases. Regulatory milestones, such as FDA approvals for novel manufacturing techniques and breakthrough therapies, highlight the significant progress within the field.

The emergence of innovative manufacturing platforms, including bioreactors, in-vivo cell engineering, and 3D cultures, is reshaping the way therapies are produced. These advancements, coupled with the potential of universal donor iPSC and CRISPR-based manufacturing techniques, are driving dynamism and scalability in the manufacturing process. However, alongside these breakthroughs, the manufacturing sector faces strategic challenges throughout the commercialization journey. From navigating regulatory compliance to optimizing production costs and ensuring quality control, addressing these hurdles is imperative to fully harness the transformative potential of cell and gene therapies.

We are thrilled to invite you to the Cell & Gene Therapy Manufacturing Summit 2025, where industry leaders and experts will converge to explore the forefront of CGT development and manufacturing. We will cover topics such as innovations in upstream and downstream processing, precision analytics, and efficient distribution. Expert panels will delve into cutting-edge bioprocessing and cell therapy manufacturing innovations. Your participation will help drive the future of CGT. We look forward to seeing you there!

WHAT TO EXPECT:

• 200+ Attendees and 100+ Organizations participating in ground-breaking discussions on advanced manufacturing technologies and cost optimization.
• 30+ Expert Speakers presenting breakthrough innovations in upstream/downstream processing, including bioreactors and 3D cultures.
• Precision Analytics and QA/QC strategies to enhance quality and scalability in cell and gene therapy manufacturing.
• Dynamic Panels and Interactive Roundtables addressing bioprocessing, AI, scalability, and sustainability.
• Exclusive CMO Showcase and Networking Lunches for key stakeholders, with a strong focus on the DACH region.
• Transformative CAR-T Therapy Sessions focusing on oncology applications and breakthroughs.
• Comprehensive Viral Vector Sessions covering lentivirus, AAV, and adenoviral vectors.
• 120+ Networking Opportunities with key DACH region stakeholders, including drinks receptions and informal gatherings.